4-Methylumbelliferyl phosphate (free acid), 95+%, 250mg

tert-Butyl 6-cyano-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate, 95.0%, 5g

tert-Butyl (2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl)carbamate, 97%, 10g

(6-((tert-Butoxycarbonyl)amino)pyridin-3-yl)boronic acid, 95.0%, 1g

1-(5-Methylpyrazin-2-yl)ethan-1-one, 97%, 100mg

(S)-N-BOC-4-(2-HYDROXYETHYL)-2,2-DIMETHYLOXAZOLIDINE, 97.0%, 10g

5-tert-Butyl-m-xylene>98.0%(GC)500mL

Hexan-2-ol, 95.0%, 500ml

1-(Phenylsulfonyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 95.0%, 1g

GC capillary column ROTI®Cap-1, 10 m, 0.25 mm, 0.10 µm, 1 Piece(s)

4-Fluoro-3-(methylsulfonyl)benzaldehyde, 95.0%, 1g

Fmoc-D-Cit-OH, 98%, 25g

(R)-tert-Butyl 3-[(pyridin-2-ylmethyl)amino]piperidine-1-carboxylate, 1g